Boston Scientific (BSX) Current Assets (2009 - 2026)

Boston Scientific has disclosed Current Assets across 18 years of filings, most recently posting $8.7 billion for Q1 2026.

• Current Assets for Q1 2026 came in at $8.7 billion, up 18.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.7 billion (up 18.39% YoY), and the FY2025 annual result was $8.8 billion, up 27.08% from the prior year.
• Current Assets came in at $8.7 billion for Q1 2026 at Boston Scientific, down from $8.8 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $9.0 billion in Q2 2024 to a low of $5.1 billion in Q1 2022.
• The 5-year median for Current Assets is $6.9 billion (2024), against an average of $7.0 billion.
• Across the five-year window, Current Assets decreased 24.79% in 2022 and jumped 52.75% in 2024, its largest moves.
• Boston Scientific's Current Assets stood at $5.8 billion in 2022, then increased by 13.09% to $6.5 billion in 2023, then climbed by 6.23% to $6.9 billion in 2024, then climbed by 27.08% to $8.8 billion in 2025, then retreated by 1.25% to $8.7 billion in 2026.
• The last three Current Assets figures came in at $8.7 billion (Q1 2026), $8.8 billion (Q4 2025), and $8.0 billion (Q3 2025), per Business Quant data.